Theses›Listed companies›SIGHT.PA
GenSight Biologics
Euronext Paris: SIGHT.PA · France
Markets it anchors
Market datarefreshed 6 Nov 2026
| Price | 0.07 EUR |
|---|---|
| Market value | $19M |
| Revenue, last 12 months | — |
| Forward P/E | -0.1x |
| EV to revenue | -109.1x |
| Gross and operating margin | 0% · 997% |
Not advice. Where I hold a position it is disclosed to members, with the reasoning.